Shuttle Pharmaceuticals Holdings, Inc. SHPH
Set alert
4.98 USD +0.03 +0.61%
As of Nov 3, 12:05 PM ET
4.48 Day range 5.00
2.58 52-week range 44.40
- YTD
- -72.33%
- 1 year
- -83.94%
- Open
- 4.53
- Prev close
- 4.95
- Mkt cap
- 23.73M
- Vol
- 14.19K
- Avg vol
- 70.97K
- EPS
- -16.87
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.48
- High
- 5.00
- Forward P/E
- 0.00
- Beta
- 0.74
- Short ratio
- 0.25
- Inst. own
- 1.81%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.06
- 200-d avg
- 2.42
- 1y target
- 0.00
Financial health
Altman Z-Score
-1.02 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 5
Valuation
P/E -0.3×
FY 2017 5y median -222× FY 2025
P/S 0.0×
FY 2017 5y median 0.0× FY 2025
P/B 1.3×
FY 2017 5y median 313× FY 2025
P/FCF -0.3×
FY 2017 5y median -259× FY 2025
EV/EBITDA -0.3×
FY 2017 5y median -362× FY 2025
EV/Sales 0.0×
FY 2017 5y median 0.0× FY 2025
FCF Yield -321.6%
FY 2017 5y median -0.4% FY 2025
Profitability
Gross Margin 0.0%
FY 2017 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2017 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2017 5y median 0.0% FY 2025
ROE -519.9%
FY 2017 5y median -162.6% FY 2025
ROIC -460.8%
FY 2017 5y median -106.0% FY 2025
ROA -111.9%
FY 2017 5y median -111.9% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2017 FY 2025
Operating Income -54.8%
FY 2017 FY 2025
EPS (diluted) 99.2%
FY 2017 FY 2025
Free Cash Flow -29.4%
FY 2017 FY 2025
Financial Health
Current Ratio 0.1×
FY 2017 5y median 1.4× FY 2025
Quick Ratio 0.1×
FY 2017 5y median 1.4× FY 2025
Debt / Equity 0.1×
FY 2017 5y median 0.1× FY 2025
Net Debt / EBITDA 0.0×
FY 2017 5y median 0.1× FY 2025
Interest Coverage -168×
FY 2017 5y median -5.7× FY 2025
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
